GENEVA — Global health officials are continuing to monitor several emerging virus variants through international surveillance networks, while emphasizing that available evidence does not currently indicate an increase in public health risk from the strains under observation.
The World Health Organization (WHO) said it remains focused on tracking genetic changes in viruses, including SARS-CoV-2, as part of routine efforts to identify mutations that could affect transmission, disease severity, diagnostic tools, treatments or vaccines. WHO officials have said ongoing genomic surveillance remains critical because viruses naturally evolve over time.
According to WHO variant-tracking updates, several SARS-CoV-2 lineages, including NB.1.8.1, XFG, BA.3.2 and KP.3.1.1, are currently classified as variants under monitoring. WHO said available assessments indicate that these variants do not appear to pose additional public health risks compared with other circulating strains.
“While monitoring the circulation of SARS-CoV-2 globally, it also remains essential to monitor their spread in animal populations and chronically infected individuals,” WHO said in a recent update on virus evolution and surveillance systems.
Health agencies have also reported monitoring developments involving other infectious diseases. In February, WHO confirmed the detection of a recombinant mpox strain containing genetic material from two previously known virus clades. Two cases were identified, one in the United Kingdom and one in India, and officials said neither patient experienced severe illness. WHO reported that no secondary cases were detected through contact tracing and that the overall global public health risk assessment remained unchanged.
The monitoring efforts come as global health authorities continue to rely on laboratory sequencing, epidemiological investigations and international data sharing to detect potential threats early. WHO launched its Coronavirus Network, known as CoViNet, to support the detection and assessment of coronavirus variants and related public health risks.
Recent WHO respiratory disease updates indicate that overall SARS-CoV-2 activity has remained relatively low globally, while surveillance programs continue to track changes in circulating viruses. Officials have cautioned that declining sequencing and reporting levels in some regions may make it more difficult to quickly identify new variants or assess their impact.
As of Monday, WHO and national health authorities said surveillance systems remain active and no changes to current global risk assessments for the monitored variants had been announced. Officials said monitoring and data collection efforts are continuing as new information becomes available.
